Cargando…
Oligometastatic non-small cell lung cancer: Current management
BACKGROUND: In the past decade, major developments have improved the survival of patients with oligometastatic non-small cell lung cancer (NSCLC). About 20% - 50% of patients with NSCLC present with oligometastases at diagnosis. For this group of patients, it seems that an increase in survival would...
Autores principales: | Román-Jobacho, Alicia, Hernández-Miguel, María, García-Anaya, María Jesús, Gómez-Millán, Jaime, Medina-Carmona, J. A., Otero-Romero, Ana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Whioce Publishing Pte. Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8259607/ https://www.ncbi.nlm.nih.gov/pubmed/34239990 |
Ejemplares similares
-
Oligometastatic non-small-cell lung cancer: current treatment strategies
por: Richard, Patrick J, et al.
Publicado: (2016) -
Current treatment landscape for oligometastatic non-small cell lung cancer
por: Garde-Noguera, Javier, et al.
Publicado: (2022) -
The Role of Surgery for Oligometastatic Non-Small Cell Lung Cancer
por: Euhus, Caleb J., et al.
Publicado: (2022) -
Management of oligometastatic non-small cell lung cancer patients: Current controversies and future directions
por: Couñago, Felipe, et al.
Publicado: (2019) -
Local Consolidative Therapy for Oligometastatic Non-Small Cell Lung Cancer
por: Santos, Patricia Mae G., et al.
Publicado: (2022)